SEC Form 4 · accession 0001209191-15-049883
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James N Wilson
Director
Period of report
Jun 2, 2015
Accepted (ET)
Jun 3, 2015 · 8:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jun 2, 2015 | M | 10,000 | $1.51 | A | 1,711,396 | D | |
| Common StockF1 | Jun 2, 2015 | S | 10,000 | $6.134 | D | 1,701,396 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock optionF2 | $1.51 | Jun 2, 2015 | M | 10,000 | D | — | May 18, 2017 | Common stock | 10,000 | 220,000 | D |
Explanation of responses
- F1Represents the weighted average sale price for the entire number of shares sold. The sale prices ranged from $6.10 to $6.16 per share.
- F2Fully exercisable